Marangio Asia, Biccari Andrea, D'Angelo Edoardo, Sensi Francesca, Spolverato Gaya, Pucciarelli Salvatore, Agostini Marco
General Surgery 3, Department of Surgery, Oncology and Gastroenterology, University of Padova, Via Giustiniani 2, 35128 Padova, Italy.
Fondazione Istituto di Ricerca Pediatrica, Città della Speranza, 35129 Padova, Italy.
Cancers (Basel). 2022 Nov 29;14(23):5903. doi: 10.3390/cancers14235903.
Bidirectional communication between cells and their microenvironment has a key function in normal tissue homeostasis, and in disease initiation, progression and a patient's prognosis, at the very least. The extracellular matrix (ECM), as an element of all tissues and cellular microenvironment, is a frequently overlooked component implicated in the pathogenesis and progression of several diseases. In the inflammatory microenvironment (IME), different alterations resulting from remodeling processes can affect ECM, progressively inducing cancer initiation and the passage toward a tumor microenvironment (TME). Indeed, it has been demonstrated that altered ECM components interact with a variety of surface receptors triggering intracellular signaling that affect cellular pathways in turn. This review aims to support the notion that the ECM and its alterations actively participate in the promotion of chronic inflammation and cancer initiation. In conclusion, some data obtained in cancer research with the employment of decellularized ECM (dECM) models are described. The reported results encourage the application of dECM models to investigate the short circuits contributing to the creation of distinct IME, thus representing a potential tool to avoid the progression toward a malignant lesion.
细胞与其微环境之间的双向通讯在正常组织稳态中起着关键作用,至少在疾病的起始、进展以及患者的预后方面也是如此。细胞外基质(ECM)作为所有组织和细胞微环境的一个组成部分,是在几种疾病的发病机制和进展中常被忽视的一个因素。在炎症微环境(IME)中,重塑过程导致的不同改变会影响ECM,逐步诱导癌症的起始以及向肿瘤微环境(TME)的转变。事实上,已经证明,改变的ECM成分与多种表面受体相互作用,触发细胞内信号传导,进而影响细胞通路。本综述旨在支持这样一种观点,即ECM及其改变积极参与慢性炎症的促进和癌症的起始。总之,描述了在癌症研究中使用脱细胞ECM(dECM)模型获得的一些数据。所报道的结果鼓励应用dECM模型来研究导致不同IME形成的短路,从而代表了一种避免向恶性病变进展的潜在工具。